Catalent Pharma Solutions Sustainability Reports

Catalent, Inc. operates as a leading global contract development and manufacturing organization (CDMO). The company provides advanced drug delivery technologies, development solutions, and clinical supply manufacturing for drugs, biologics, gene therapies, and consumer health products.

Sector: Manufacturing

Country: United States

Exchange: New York Stock Exchange

LEI: 549300HALRZ339MSTH85

FIGI: BBG005XR47N7

5 reports from 2023 to 2026

• Catalent Pharma Solutions 2026 Human Rights Statement
• Catalent Pharma Solutions 2025 Global Anti-Bribery and Anti-Corruption Policy
• Catalent Pharma Solutions 2025 Modern Slavery Statement
• Catalent Pharma Solutions 2024 Anti-Modern Slavery Policy
• Catalent Pharma Solutions 2023 Corporate Social Responsibility Report